BOSTON--(BUSINESS WIRE)--Point Therapeutics, Inc. (NASDAQ: POTP) today reported financial results for the fiscal quarter ended March 31, 2007. Point reported a net loss of $5,279,000, or $0.14 per basic and diluted share, in the first quarter of 2007, compared with a net loss of $7,857,000, or $0.24 per basic and diluted share, in the first quarter of 2006.
